Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16870)	5/21/2004 10:08:30 AM
From: Bluegreen	Respond to of 17367

Hey Bob, MAKING MONEY has ABSOLUTELY NOTHING TO DO WITH SENSES or BRAVADO on message boards.

To: Robert K. who wrote (16870)	5/21/2004 10:58:55 AM
From: Edscharp	Read Replies (1) \| Respond to of 17367

Robert, Bluegreen is punch-drunk. If I were you I'd wait a few weeks for him to heal from his wounds before praising him. Actually, I don't blame any of you. If I made a career of following the ups and downs of Xoma like so many of you on this thread have I'd have some slips from reality as well. Though I have a lot of admiration for George this applies to him as well. I've never met anybody who follows a single stock as steadfastly as he and yet has never been able to bring himself to vote for a single thing that Management has ever proposed.

To: Robert K. who wrote (16870)	5/22/2004 10:05:23 AM
From: Robert S.	Read Replies (2) \| Respond to of 17367

Welcome back to the merry pranksters. Message 13818267 Mycoprex deal? Hmm. A deal could probably happen at any time if xoma didnt care to haggle for terms. If you listen to the company, perhaps a deal is not close BUT>Castello smoked me on the neuprex deal. That said, anything is possible. This much I do know. Mycoprex holds a lot more potential than promise. Its novel, cidal, oral, safer, synergistic. Any single one is a big factor. Combined they rock. Jack understands this as does pharma. Genimune, one of my past favorites is back in vogue. I hear its stimulating unexpected interest. I hope xoma keeps it though. As long as we can deveolp it,>I prefer it stay in house. ING-1> I cant wait. Antiangio>a wild wild card. Standard K Always good for a chuckle, you joker!